Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

✍ Scribed by I. J. van den Elskamp; B. Boden; V. Dattola; D. L. Knol; M. Filippi; L. Kappos; F. Fazekas; K. Wagner; C. Pohl; R. Sandbrink; C. H. Polman; B. M. J. Uitdehaag; F. Barkhof

• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 133 KB
• Volume: 52
• Category: Article
• ISSN: 0028-3940
• DOI: 10.1007/s00234-009-0645-1